Most of the millions in the U.S. who are infected with hepatitis C can't afford the cure. Some say the U.S. could save money and cure more people if it bought the drugmaker Gilead Sciences Inc.
Read more on NPR
Copyright 2014 All Rights Reserved / Privacy Policy / Sitemap / Contact Us
Edited by / loobobilly / Powered by / M.S.Aditya